-
Electronic (PDF)
-
Site License
-
Enterprisewide
SpectraScience, Inc. (SCIE) - Financial and Strategic SWOT Analysis Review
GlobalData, September 2011, Pages: 36
SpectraScience, Inc. (SCIE) - Financial and Strategic SWOT Analysis Review
Summary
SpectraScience, Inc. (SpectraScience) is a medical device company, which is engaged in the design, development, manufacture and marketing of spectrophotometers. It offers WavSTAT Optical Biopsy System, which is a minimally invasive technology that optically scans tissue in real-time to differentiate between normal and pre-cancerous or cancerous tissue, without the need to remove tissue from the body. It is also engaged in developing an additional application for the detection of pre-cancerous and cancerous tissue in the esophagus. The company has expanded its product offerings to cervical cancer and pre-cancer detection through its acquisition of Luma Imaging Corporation. It is headquartered in California, the US.
SpectraScience, Inc. Key Recent Developments
Jul 27, 2011: SpectraScience Announces Updates To Business Outlook
Mar 04, 2011: SpectraScience Addresses Commencement Of Trading On OTCQB
Dec 22, 2010: SpectraScience Provides Operational Update And Strategic Plan For Fiscal Year 2011
Dec 01, 2010: SpectraScience Appoints Michael Oliver As President, CEO
Oct 25, 2010: SpectraScience Announces Strategic Restructuring Of Business
This comprehensive SWOT profile of SpectraScience, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
SpectraScience, Inc. - Key Facts
SpectraScience, Inc. - Key Employees
SpectraScience, Inc. - Key Employee Biographies
SpectraScience, Inc. - Major Products and Services
SpectraScience, Inc. - Medical Equipment Pipeline Products Data
SpectraScience, Inc. Pipeline Products by Equipment Type
SpectraScience, Inc. Pipeline Products by Development Stage
SpectraScience, Inc. - History
SpectraScience, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
SpectraScience, Inc. - Business Description
SpectraScience, Inc. - SWOT Analysis
SWOT Analysis - Overview
SpectraScience, Inc. - Strengths
Strength - Proprietary WavSTAT Technology
Strength - Intellectual Property
Strength - Luma Cervical Imaging System
Weakness - History of Losses
Opportunity - Distribution Partnerships
Opportunity - Market Potential – Cancer
Opportunity - Changing Demographics
Threat - Rapid Technological Change
Threat - Stringent Government Regulations
Threat - Competitive Atmosphere
SpectraScience, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
SpectraScience, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
SpectraScience, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
SpectraScience, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 27, 2011: SpectraScience Announces Updates To Business Outlook
Mar 04, 2011: SpectraScience Addresses Commencement Of Trading On OTCQB
Dec 22, 2010: SpectraScience Provides Operational Update And Strategic Plan For Fiscal Year 2011
Dec 01, 2010: SpectraScience Appoints Michael Oliver As President, CEO
Oct 25, 2010: SpectraScience Announces Strategic Restructuring Of Business
Oct 13, 2010: SpectraScience Announces Resignation Of Jim Hitchin As Chairman
Mar 23, 2010: FDA Conducts Second Inspection At SpectraScience Facility
Mar 23, 2010: FDA Conducts Second Inspection At SpectraScience Facility
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Diversified Ophthalmics, Inc.
Microspecalities, Inc.
Xillix Technologies Corp.
MediSpectra, Inc.
SensiVida Medical Technologies, Inc
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
